These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16409180)

  • 21. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.
    Oldenburg J; Kulkarni R; Srivastava A; Mahlangu JN; Blanchette VS; Tsao E; Winding B; Dumont J; Jain N
    Haemophilia; 2018 Jan; 24(1):77-84. PubMed ID: 29082639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States.
    Witmer C; Presley R; Kulkarni R; Soucie JM; Manno CS; Raffini L
    Br J Haematol; 2011 Jan; 152(2):211-6. PubMed ID: 21114482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access.
    Nijdam A; Kurnik K; Liesner R; Ljung R; Nolan B; Petrini P; Fischer K;
    Haemophilia; 2015 Jul; 21(4):444-50. PubMed ID: 25582494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy.
    Lindvall K; Astermark J; Björkman S; Ljung R; Carlsson KS; Persson S; Berntorp E
    Haemophilia; 2012 Nov; 18(6):855-9. PubMed ID: 22681244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
    Osooli M; Steen Carlsson K; Astermark J; Berntorp E
    Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling lifelong effects of different prophylactic treatment strategies for severe haemophilia A.
    Fischer K; Lewandowski D; Janssen MP
    Haemophilia; 2016 Sep; 22(5):e375-82. PubMed ID: 27353496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of three-year-old boy with severe haemophilia A on prophylaxis identified with a chronic subdural haematoma 2 years after the first episode of acute subdural bleeding.
    Sakata K; Matsumoto T; Wada H; Kumamoto T; Iwamoto S; Ohishi K; Takahashi J; Katayama N; Komada Y
    Haemophilia; 2012 Jan; 18(1):e1-2. PubMed ID: 21899665
    [No Abstract]   [Full Text] [Related]  

  • 30. Forum on: the role of recombinant factor VIII in children with severe haemophilia A.
    Franchini M; Coppola A; Molinari AC; Santoro C; Schinco P; Speciale V; Tagliaferri A
    Haemophilia; 2009 Mar; 15(2):578-86. PubMed ID: 19187188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world resource use and costs of haemophilia A-related bleeding.
    Shrestha A; Eldar-Lissai A; Hou N; Lakdawalla DN; Batt K
    Haemophilia; 2017 Jul; 23(4):e267-e275. PubMed ID: 28574162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
    Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Successfull extirpation of femoral pseudotumour in a patient with severe haemophilia A and an inhibitor to factor VIII].
    Marisavljević D; Glisić M; Elezović I; Popović A; Rolović Z
    Srp Arh Celok Lek; 1991; 119(11-12):338-42. PubMed ID: 17974380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world.
    Sørensen B; Benson GM; Bladen M; Classey S; Keeling DM; McLaughlin P; Yee TT; Makris M
    Haemophilia; 2012 Jul; 18(4):598-606. PubMed ID: 22151135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight(®) ) in previously treated patients with severe haemophilia A: interim results of the guardian(™) 2 extension trial.
    Ozelo M; Misgav M; Abdul Karim F; Lentz SR; Martin-Salces M; Matytsina I; Saugstrup T; Santagostino E
    Haemophilia; 2015 Sep; 21(5):e436-9. PubMed ID: 26058730
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of haemophilic synovitis: prophylaxis.
    Lee CA
    Haemophilia; 2007 Nov; 13 Suppl 3():20-5. PubMed ID: 17822517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of enhanced half-life factor VIII and IX in the treatment of haemophilia.
    Mahdi AJ; Obaji SG; Collins PW
    Br J Haematol; 2015 Jun; 169(6):768-76. PubMed ID: 25754016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on-demand replacement therapy.
    Mondorf W; Kalnins W; Klamroth R
    Haemophilia; 2013 Jul; 19(4):558-63. PubMed ID: 23560639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interim data on long-term efficacy, safety and tolerability of a plasma-derived factor VIII concentrate in 109 patients with severe haemophilia A.
    Nemes L; Pollmann H; Becker T
    Haemophilia; 2012 Jul; 18(4):496-502. PubMed ID: 22250808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.